TY  - GEN
AU  - Morris,D L
TI  - A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma
SN  - 0008-543X
PY  - 1996///0722
KW  - Antineoplastic Agents, Hormonal
KW  - administration & dosage
KW  - Carcinoma
KW  - drug therapy
KW  - Clinical Trials, Phase III as Topic
KW  - Colonic Neoplasms
KW  - Hormone Antagonists
KW  - Humans
KW  - Neoplasm Staging
KW  - Octreotide
KW  - Rectal Neoplasms
KW  - Somatostatin
KW  - Survival Rate
N1  - Publication Type: Comment; Letter
UR  - https://doi.org/10.1002/(SICI)1097-0142(19960501)77:9<1956::AID-CNCR29>3.0.CO;2-Y
ER  -